These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 17920818)

  • 61. [Bullous pemphigoid: diagnosis and therapy].
    Kneisel A; Hertl M
    Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract]   [Full Text] [Related]  

  • 63. Biological predictors shared by dementia and bullous pemphigoid patients point out a cross-antigenicity between BP180/BP230 brain and skin isoforms.
    Julio TA; Vernal S; Massaro JD; Silva MC; Donadi EA; Moriguti JC; Roselino AM
    Immunol Res; 2018 Oct; 66(5):567-576. PubMed ID: 30220011
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J; Shears E; Powell J; Wojnarowska F
    Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
    Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
    Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BP230- and BP180-specific auto-antibodies in bullous pemphigoid.
    Thoma-Uszynski S; Uter W; Schwietzke S; Hofmann SC; Hunziker T; Bernard P; Treudler R; Zouboulis CC; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2004 Jun; 122(6):1413-22. PubMed ID: 15175032
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
    Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
    J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
    J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid.
    Blöcker IM; Dähnrich C; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Zillikens D; Schmidt E
    Br J Dermatol; 2012 May; 166(5):964-70. PubMed ID: 22242606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-BP180 Autoantibodies Are Present in Stroke and Recognize Human Cutaneous BP180 and BP180-NC16A.
    Wang Y; Mao X; Wang D; Hammers CM; Payne AS; Wang Y; Jin H; Peng B; Li L
    Front Immunol; 2019; 10():236. PubMed ID: 30863396
    [No Abstract]   [Full Text] [Related]  

  • 71. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
    Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
    Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D
    Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid.
    Messingham KN; Holahan HM; Frydman AS; Fullenkamp C; Srikantha R; Fairley JA
    PLoS One; 2014; 9(9):e107725. PubMed ID: 25255430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases.
    Moriuchi R; Nishie W; Ujiie H; Natsuga K; Shimizu H
    J Dermatol Sci; 2015 Apr; 78(1):21-5. PubMed ID: 25724363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of MHC Class II genes in the pathogenesis of pemphigoid.
    Zakka LR; Reche P; Ahmed AR
    Autoimmun Rev; 2011 Nov; 11(1):40-7. PubMed ID: 21782980
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
    Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
    Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.
    Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R
    Front Immunol; 2021; 12():569287. PubMed ID: 33841390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A case of bullous pemphigoid with IgG antibodies against LAD-1, but not BP180 NC16a domain or BP230.
    Miyashita K; Iioka H; Miyagawa F; Ishii N; Hashimoto T; Asada H
    Eur J Dermatol; 2018 Apr; 28(2):248-250. PubMed ID: 29378676
    [No Abstract]   [Full Text] [Related]  

  • 80. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.